CancerNetwork®
@cancernetwrk
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
ID: 22195223
http://www.cancernetwork.com 27-02-2009 21:48:14
20,20K Tweet
29,29K Takipçi
625 Takip Edilen
An ORR of 74% (95% CI, 48.8%-90.9%) among 19 evaluable patients was observed, with anti-tumor activity occurring across all dose levels. #lcsm | Alex Spira, M.D. cancernetwork.com/view/dll3-targ…